Roche

Fierce Pharma

2nd patient dies after Sarepta's DMD gene therapy Elevidys

Sarepta has suspended giving Elevidys to non-ambulatory DMD patients in the commercial setting while it seeks FDA approval of a risk mitigation plan.

Angus Liu Jun 16, 2025 10:58am

Graphic showing arrows missing the bullseye on a target

How 'overenthusiasm' led to Big Pharma's risky $6B TIGIT gamble

Jun 13, 2025 8:00am

layoffs cut staff reduction workforce

Genentech lays off 143 workers at South San Francisco campus

Jun 11, 2025 12:25pm

Glowing puzzle piece fitting into puzzle

Vividion secures clinical-stage WRN inhibitor from Roche

Jun 4, 2025 9:21am

Businessman climbing steps to pluck a star from the sky

Roche links BTK drug to low relapse rate across 96-week MS trial

May 30, 2025 5:19am

DNA genome CRISPR gene editing

Roche taps Broad Institute to test SBX sequencing in the clinic

May 23, 2025 10:30am